Document is current
Any future updates will be listed below
-
Authors
de Menezes, Maria N. https://orcid.org/0000-0003-3231-0620
Chen, Amanda X. Y. https://orcid.org/0000-0002-1388-9510
Kulkarni, Nihali
Sampurno, Shienny
Saw, Nicole Y. L.
Yap, Kah Min https://orcid.org/0000-0001-5009-9895
Pérez-Núñez, Iván
Roth, Sara
Deguit, Christian Deo T.
Haugen, Brandon
Ramsbottom, Kelly M.
Munoz, Isabelle https://orcid.org/0000-0001-6510-5696
Beavis, Paul A. https://orcid.org/0000-0002-2116-013X
Parish, Ian A. https://orcid.org/0000-0003-3528-478X
-
Funding
Funding for this research was provided by:
Victorian Cancer Agency (MCRF21019)
Victorian Cancer Agency (MCRF20011)
CLEARBridge Foundation
Cancer Research Institute (Lloyd J. Old STAR Grant CRI5578)
- License Information
-
More Information
Article History
Received: 30 January 2025
Accepted: 3 February 2026
First Online: 17 February 2026
Competing interests
: The authors declare the following competing interests. I.A.P. declares research funding from AstraZeneca, Bristol-Myers-Squibb and Roche Genentech. P.A.B. declares research funding from Bristol-Myers-Squibb. The remaining authors declare no competing interests.
